PARIS--(BUSINESS WIRE)--DNA Script today announced an oversubscribed Series B fundraising of $38.5M led by LSP, one of Europe’s largest and most experienced healthcare investment firms. Bpifrance, ...
DNA Script will receive up to $9.35 million to leverage the company's novel enzymatic DNA synthesis (EDS) technology for the project This is the second announced project[1] where DNA Script has been ...
DNA Script was created to revolutionize DNA write with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The ...
The benchtop DNA printer developer DNA Script has expanded upon its most recent venture capital funding round, tacking on an additional $35 million for a grand total of $200 million. The financing ...
DNA Script SAS raised a $50 million extension to its series B financing, for a total yield of $89 million. Paris-based DNA Script has earmarked the funds to advance the development of its suite of ...
Company will receive up to $5 Million in grant funds from DARPA as part of the agency's Nucleic Acids On-Demand World-Wide Program to plan for and prevent the next viral pandemic SOUTH SAN FRANCISCO, ...
Following the launch of its benchtop DNA printer earlier this year, DNA Script has secured a hefty $165 million to take its platform to the masses. The nine-digit proceeds represent a big leap in DNA ...
SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a leader in Enzymatic DNA Synthesis (EDS), today announced the appointment of Don Kania, Ph.D. as Chairman of the Board of Directors, ...
DNA Script SAS nabbed $165 million in a series C fundraising round to support commercialization of the company’s Syntax platform and expand its portfolio of products powered by enzymatic DNA synthesis ...
Synthesising DNA for Bio Science research and development is costly in terms of time and resources. It’s also a fast-growing, big business. The global Gene Synthesis market will reach over $21 billion ...
A team including DNA Script, a Paris-based synthetic nucleic acid manufacturer, has been awarded a contract worth up to $23 million from the US Intelligence Advanced Research Projects Activity for DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback